A Joint venture for nanotechnology commercialization
15 December 2007Recently California Nanosystems Institute (NSI) and Nanopacific Holdings Inc. announces a partnership for commercializing nanotechnology. The new partnership will enhance commercialization of specific mechanized nanoparticle based technology that could benefit millions of cancer sufferers. The new joint venture will also provide fund for further research to be carried out at Nano Machine Centre and will also broaden the areas of research.
The new joint venture will establish the safe delivery of approved and established chemotherapeutic agents to cancer cells and that too in the reduced dosage through mechanized nanoparticles. These mechanized nanoparticles can easily identify cancer cells while leaving behind the pure healthy cells and will enablethe delivery of drugs at the desired sites only.
These nanoparticles are porous in nature and therefore these are not only capable to store but the drug can also selectively released. Actually the process of taking and releasing of drug is controlled through a nanoscale gate and thus the mechanized nanoparticle based technology is affective in controlling cancer.
Related Posts:
- Production of new innovative Li-ion batteries
- Nanotech commercialization could suffer
- Nanotechnology $1 trillion market by 2015
- Russia enhances Nanotech funding
- More Funding for Materials Research in Nanotechnology
- $20 Million grant for solar-fuel power plant
- Nanotechnology Initiatives in Pennsylvania
- Bangalore Nano to be held in December 2008
- European Union to spend 3 bn Euro on Nanotechnology
- IIT Develops Biosensor for Detecting Heart Disease
Top Of Page | Trackback
If you found this page useful, consider linking to it. Simply copy and paste the code below into your web site.
It will look like this: A Joint venture for nanotechnology commercialization
